The Translational Research Grant (TRG) program funds projects that explore commercial applications or initiate the early commercial development of university-held life sciences inventions. The technology must have the potential to solve a real-world problem as a commercial product in the life sciences sector.
Goals of the TRG program:
- Transform basic research discoveries into product-focused translational research development
- Generate data that addresses important product development milestones, addresses the concerns of potential licensees or investors, or otherwise de-risks the technology for a specific commercial application
- Enable strategic “go/no-go” decision-making regarding further technology development or pursuit of intellectual property protection
- Enable technology licensing efforts by the university
- Establish goal-oriented partnerships between university scientists, product development professionals, and key stakeholders
Proposals will be evaluated on the composition of the project team, including a project manager, and the setting of relevant, realistic, and achievable milestones during the product development tasks. See the guidelines for details.
Applicants must be researchers employed by North Carolina-based universities or nonprofit research institutes. Technical projects may be conducted at awardee institutions or outsourced to contract research organizations.
TRG FAQs can be found here: www.ncbiotech.org/grant-faq
The guidelines and application materials listed below are for informational purposes only. The FY2024 materials will be posted closer to the proposal deadline.
How to Submit your Proposal:
Important First Step: The Principal Investigator for the proposal must register for an account on the NCBiotech Funding Portal before the deadline to submit a proposal.
Click here for instructions and more information.
Translational Research Grant
(with project manager supplement)
(without project manager supplement)
Wednesday, August 23, 2023 (noon)
Wednesday, January 31, 2024 (noon)
For questions or more information, contact:
Michelle Collins, MPA, CRA, CPRA
Director, Grant Process Operations
Science and Technology Development
(919) 549-8845 | firstname.lastname@example.org